[Branched antimicrobial peptides]

Area of Science:

• Peptide Synthesis and Medicinal Chemistry
• Antimicrobial Research

Background:

• Antimicrobial peptides (AMPs) are crucial in innate immunity, but their therapeutic application is limited by stability and cost.
• Developing synthetic peptide analogs with enhanced stability and potent activity is a key research area.
• Structure-activity relationships of branched peptides are underexplored for antimicrobial applications.

Purpose of the Study:

• To synthesize novel branched peptides based on RLAR and KLAR tetrapeptides.
• To evaluate the antimicrobial activity of these branched peptides against bacterial pathogens.
• To assess the selectivity of the synthesized peptides towards bacterial cells versus human erythrocytes.

Main Methods:

• Synthesis of branched peptides using glutamic acid bis(pentafluorophenyl) ester and tetrapeptides RLAR and KLAR.
• Determination of minimal antimicrobial concentrations (MACs) against Escherichia coli.
• Assay for hemolytic activity on human erythrocytes.

Main Results:

• Branched peptides E(RLAR)2, E[E(RLAR)2]2, E(KLAR)2, and E[E(KLAR)2]2 were successfully synthesized.
• Antimicrobial activity increased with peptide branching, with minimal concentrations as low as 12 microM for E. coli.
• The synthesized peptides exhibited antimicrobial potency comparable to natural AMPs like temporin, magainin, and dermaseptin.
• No significant hemolytic activity was observed on human erythrocytes, indicating selectivity.

Conclusions:

• Branched peptide architecture enhances antimicrobial efficacy.
• The synthesized peptides represent a promising class of synthetic antimicrobials with potent activity and good selectivity.
• These findings support further investigation of branched peptides as potential therapeutic agents against bacterial infections.